Package 68788-8664-1

{"route": ["ORAL"], "spl_id": "fbf59a4c-b7b9-4e91-b893-75ef09eee644", "openfda": {"nui": ["N0000175599", "N0000020026"], "unii": ["742SXX0ICT"], "rxcui": ["402019"], "spl_set_id": ["09ad27a1-3908-4533-b84c-7a7fd3514101"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET in 1 BOTTLE (68788-8664-1)", "package_ndc": "68788-8664-1", "marketing_start_date": "20240513"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-8664-3)", "package_ndc": "68788-8664-3", "marketing_start_date": "20240513"}, {"sample": false, "description": "7 TABLET in 1 BOTTLE (68788-8664-7)", "package_ndc": "68788-8664-7", "marketing_start_date": "20240513"}], "brand_name": "TADALAFIL", "product_id": "68788-8664_fbf59a4c-b7b9-4e91-b893-75ef09eee644", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "68788-8664", "generic_name": "tadalafil", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TADALAFIL", "active_ingredients": [{"name": "TADALAFIL", "strength": "20 mg/1"}], "application_number": "ANDA210609", "marketing_category": "ANDA", "marketing_start_date": "20240513", "listing_expiration_date": "20261231"}